Patent details
EP1666500 Title: Use of trifunctionel antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy
Basic Information
- Publication number:
- EP1666500
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP040284739
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Use of trifunctionel antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy
- French Title of Invention:
- Utilisation d'anticorps trifonctionnels permettant de diminuer le risque de GvDH dans le traitement cellulaire antitumoral allogénique
- German Title of Invention:
- Verwendung trifunktionaler Antikörper zur Risikoreduzierung von GvHD in einer allogenetischen anti-Tumor Zelltherapie
- SPC Number:
Dates
- Filing date:
- 01/12/2004
- Grant date:
- 21/09/2011
- EP Publication Date:
- 21/09/2011
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2006
- EP B1 Publication Date:
- 21/09/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 01/12/2011
- Expiration date:
- 01/12/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/12/2004
- Name:
- TRION PHARMA GMBH
- Address:
- Frankfurter Ring 193a, 80807 München, Germany (DE)
Inventor
1
- Name:
- Lindhofer Horst, Dr.
- Address:
- Germany (DE)
2
- Name:
- Morecki Shoshana
- Address:
- Israel (IL)
3
- Name:
- Slavin Shimon
- Address:
- Israel (IL)
Classification
- Main IPC Class:
- C07K 16/28;
| Filing date | Document type | Number of pages |
|---|